Nat. Rev. Neurol. doi: /nrneurol

Slides:

Advertisements

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Advertisements

Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;

Changing demographics and the impact on dementia

Figure 3 Life expectancy at birth in all countries included

Figure 1 Perivenous distribution of multiple sclerosis lesions

Figure 2 The US Centers for Disease Control and

Figure 4 Time course of the development of physiological changes

Nat. Rev. Neurol. doi: /nrneurol

with undiagnosed diabetes mellitus by three diagnostic criteria

Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Overview of risk factors for Parkinson disease dementia

Volume 382, Issue 9902, Pages (October 2013)

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Proportion of patients for whom NEDA

Figure 5 Number of AHSCT procedures for

Figure 1 Diagnostic tiers of Parkinson disease as single disease

Figure 4 Prevalence of HFpEF and HFrEF by age

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Algorithm for immunosuppressive treatment

Nat. Rev. Neurol. doi: /nrneurol

The Changing Face of Cancer in Iowa

Figure 1 Principles of therapeutic ultrasound

Nat. Rev. Neurol. doi: /nrneurol

Volume 382, Issue 9902, Pages (October 2013)

Figure 1 Clinical correlates of neurodegeneration in MS

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Genetic pleiotropy in ALS

Figure 1 Evolution of multiple sclerosis

Figure 2 Haemorrhagic stroke prevalence and mortality

Figure 1 The trajectory of cognitive ageing

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Nat. Rev. Neurol. doi: /nrneurol

DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Diagnostic scheme for MSA

Figure 3 Stroke-related deaths and DALYs by country development status

Figure 2 Age-specific prevalence of common comorbidities

Nat. Rev. Neurol. doi: /nrneurol

Figure 6 Combining population-wide and high-risk strategies

Figure 1 Ischaemic stroke prevalence and mortality

Nat. Rev. Neurol. doi: /nrneurol

UK Renal Registry 16th Annual Report

Figure 2 Logistical requirements for autologous

Figure 3 Potential interplay between physiological

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Clinical aspects of LGMD subtypes

Figure Association of hippocampal subfield volumes to cognition by neopterin level, volumes, and cognition adjusted for age, education, race, sex, and.

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Timing of the effects of deep brain stimulation

Figure 5 Interaction between infarction and amyloid deposition

Figure 1 A large number of genes are potentially associated with CIPN

Temporal changes in population rates of cardiac services, demographics, and AMI prevalence (relative to 1992) David A. Alter, et al, Circulation 2006;113;

Nat. Rev. Cardiol. doi: /nrcardio

Incidence of choking in London, UK, by gender per 1000 population by age group. Incidence of choking in London, UK, by gender per 1000 population by age.

UK Renal Registry 15th Annual Report

Figure 3 Rett syndrome severity and age at diagnosis by mutation type

Rahilly-Tierney CR et al. Circulation 2009;120:1491-7

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 A case of early-onset PSD

Figure 2 Network connections of the hypothalamus

Figure 2 Time from incident ADS event to MS diagnosis

Figure Prevalence for MS cumulated over 10 years in the United States per 100,000 population by age and sex 2010 Prevalence for MS cumulated over.

Presentation transcript:

Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.63 Figure 1 Odds ratios and prevalence ratios reported in nine studies of dementia prevalence Figure 1 | Odds ratios and prevalence ratios reported in nine studies of dementia prevalence. Reported figures are the ratios of the prevalence estimate for new cohorts to those for old cohorts. If prevalence estimates remain the same across two cohorts, the ratio is 1.0. If estimates are higher in the new cohort than the old cohort, the ratio is greater than 1.0. Estimates are adjusted as follows: Gothenburg study and HRS, unadjusted; IIDP, adjusted for age; Nordanstig, Zaragoza, Bordeaux and Hisayama studies, adjusted for age and sex; Stockholm study, adjusted for age, sex and education; CFAS, adjusted for age, sex, area and deprivation. In the Bordeaux study, clinical diagnosis was made by neuropsychologists using criteria in the Diagnostic and Statistical Manual III revised, and algorithmic diagnosis was based on cognitive and functional ability tests. CFAS, Cognitive Function and Ageing Study; HRS, Health and Retirement Study; IIDP, Indianapolis–Ibadan Dementia Project. Wu, Y.-T. et al. (2017) The changing prevalence and incidence of dementia over time — current evidence Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.63